Sartorius Stedim Biotech is a life science group providing solutions for the biopharmaceutical industry and research sector. The company supplies products and services for drug discovery, development, and biomanufacturing, covering the entire value chain from laboratory research to commercial production. Its portfolio includes single-use bag systems, bioreactors, process filtration, chromatography, cell culture media, and cell line development platforms. Key products and services include the CellCelector CLD Platform, Biosafe Rapid Transfer Port, and integrated bag systems for bioprocessing. The company serves customers in Europe, North America, and Asia, with manufacturing, R&D, and sales sites in these regions. Sartorius Stedim Biotech was established in 2007 through the merger of Stedim and the Biotech Division of Sartorius. Stedim was founded in 1978, originally focusing on parenteral nutrition bags before expanding into biotechnology. The group has expanded its portfolio through acquisitions, including Integrated Biosystems Inc. and Isolateur Dénominateur Commun, to offer integrated single-use technologies and aseptic transfer solutions. It partners with organizations such as Nibrt for training in intensified bioprocessing and supports diagnostic improvements through collaborations like the one with Jambo Labs in Tanzania.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Medical Instruments & Supplies Homepage sartorius.com
Sector Healthcare IR page sartorius.com/en/company/sartorius-ag-investor-relations
Tags
biopharmaceutical manufacturing, single-use systems, bioreactors, process filtration, cell culture media, cell line development, chromatography, aseptic transfer, life science research, biomanufacturing, CellCelector CLD Platform, Biosafe Rapid Transfer Port, Stedim, Integrated Biosystems Inc., Isolateur Dénominateur Commun, Nibrt, Jambo Labs, action medeo
Press page sartorius.com/en/company/newsroom

Metrics

Valuation  
Market cap € 20.538B
Market cap (USD) $ 23.031B
P/E 77.33
PEG —
P/BV 4.98
P/S 6.92
P/OCF 29.67
P/FCF —
Dividend yield 0.33%
Turnover / mcap —
Returns  
ROE 6.5%
ROI 4.4%
ROIC 6.2%
Profit margin 9.0%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -32.8%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 45.3%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -17.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue 2.968B 2.78B 2.776B 3.493B 2.887B 1.91B —
Net profit 265.6M 175.1M 309.7M 876.1M 414.413M 335.932M 236.036M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Share price 211.1 — — 336.4 336.4 — —
P/E 5y avg 62.48 — — — — — —

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Borrowings, current (EUR) — 13.1M 25.5M 4.5M 57.7M 39.5M 557M
Borrowings, non-current (EUR) — 516M 521M 1.02B 3.51B 2.68B 1.87B
Lease liabilities (EUR) — 58.3M 78.9M 111M 115M 146M 175M
Cash and deposits (EUR) 28.2M 59.8M 224M 107M 117M 679M 426M
Intangible assets (EUR) — 572M 684M 877M 1.74B 1.63B 1.54B
Net debt (borrowings + leases - cash) (EUR) — 527M 402M 1.03B 3.57B 2.19B 2.17B
Cash flow detail
Operating cash flow (EUR) — 417M 696M 612M 746M 815M 692M
Change in receivables (cash effect) (EUR) — -73.9M -87.3M -65.8M 162M 38.3M 42.9M
Change in inventories (cash effect) (EUR) — -117M -275M -218M 131M 208M -46.4M
Change in payables (cash effect) (EUR) — 143M 210M -68M -87.9M 2.8M -21.4M
Dividends paid (cash effect) (EUR) — -31.3M -62.7M -116M -133M -67.1M -67.1M
Interest paid (cash effect) (EUR) — -8.06M -8.26M -10.3M -117M -177M -154M
Income taxes paid (cash effect) (EUR) — -114M -167M -221M -136M -134M -149M
Operating cash flow before change in receivables (EUR) — 491M 783M 678M 584M 777M 649M
Income detail
Research and development expense (EUR) — 84.5M 110M 132M 130M 144M 133M
↳ 5y CAGR +9.5%
Total comprehensive income (EUR) — 308M 457M 874M 289M 227M 162M
Comprehensive income to owners (EUR) — 305M 456M 870M 287M 225M 163M
Reported Feb 16, 2022 Feb 16, 2022 Feb 16, 2022 Feb 16, 2023 Feb 15, 2024 Feb 14, 2025 Feb 16, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Multimedia

Multimedia

In this section you will find press photos and footage material, presentations and publications, as well as the Sartorius logo for download.

[icon-file-image
\

Image/Video](https://www.sartorius.com/en/company/newsroom/multimedia-downloads#id-1193932)

[icon-file-pdf
\

Publications](https://www.sartorius.com/en/company/newsroom/multimedia-downloads#id-1176502)

[icon-signet
\

Sartorius Logo](https://www.sartorius.com/en/company/newsroom/multimedia-downloads#id-16756)

Image and Video

Please note

These images are for editorial use only. If there are no references to the license terms of an image, you are requested to name Sartorius AG as the copyright owner. Pictures may not be modified or used for commercial purposes or advertising.

Management

Executive Board Sartorius Group

Explore Management

March 04, 2026 | Chairman | CEO

Michael Grosse

JPEG | 7.7 MB

Download

March 04, 2026 | CFO

Florian Funck

JPEG | 7.8 MB

Download

March 04, 2026 | Bioprocess Solutions Division

René Fáber

JPEG | 8.3 MB

Download

March 04, 2026 | Lab Products & Services Division

Alexandra Gatzemeyer

JPEG | 8.3 MB

Download

Executive Board

JPEG | 8.2 MB | March 04, 2026

Download

Explore Management

Locations

Locations

Visit Local Contact

Sartorius Campus | Göttingen, Germany

JPEG 1.4 MB

Download

Sartorius Campus | Göttingen, Germany

JPEG 903.0 KB

Download

Sartorius Campus | Göttingen, Germany

JPEG 923.2 KB

Download

Plant in Guxhagen, Germany

JPEG 2.3 MB

Download

Plant in Ulm, Germany

JPEG 6.0 MB

Download

Plant in Aubagne, France

JPEG 1.6 MB

Download

US Headquarters | Bohemia, New York

JPEG 8.9 MB

Download

Office building in Shanghai, China

JPEG 6.4 MB

Download

Office Building | Beijing, China

JPEG 9.9 MB

Download

Customer Interaction Center | Beijing, China

JPEG 1.5 MB

Download

Plant in Yauco, Puerto Rico

JPEG 3.5 MB

Download

Plant in Bangalore, India

JPEG 8.0 MB

Download

Plant in Havant, United Kingdom

JPEG 653.1 KB

Download

Plant in Beit Haemek, Israel

JPEG 2.2 MB

Download

Plant in Adjovscina, Slovenia

JPEG 6.6 MB

Download

Plant in M’Hamdia, Tunisia

JPEG 1.1 MB

Download

Center of Excellence in Ann Arbor, USA

JPEG 679.2 KB

Download

Plant in Illkirch, France

JPEG 1.7 MB

Download

Visit Local Contact

Products

Integrated Solutions for the Manufacture of Biopharmaceuticals

Safety, flexibility and efficiency are playing an ever-increasing role in the manufacture of biopharmaceuticals. Configurable and scalable system solutions, such as Flexact®, can be used in all process steps – in preparation of media and buffers, cell harvesting, crossflow filtration, viral clearance, virus inactivation, polishing and in the form - fill and form - transfer process steps.

Process Development

The Ambr® 15 Microbioreactor Vessel determines optimal production conditions and is therefore an important tool for process development.

Analysis of Cell Culture Processes

Cell cultivation is initially tested at the lab-scale level. In trial series, the parameters of the individual samples are altered, such as pH, oxygen content and temperature, to find the conditions that are most conducive to optimal cell growth. During the cultivation process, the cultures are continually sampled and analyzed.

Safe Storage of Biologics

Transportation and storage of biologics are key intermediate steps in the production of biopharmaceuticals. To ensure the safety of these products across the entire process chain, these liquids are filled into sterile single-use bags and stored in specially designed tanks.

Cell Cultivation in Biopharmaceutical Processes

To enable cells to grow optimally in the production of active pharmaceutical ingredients, cells are cultivated in a bioreactor under controlled conditions. Important factors for cell growth include the composition of the nutrient medium, mixing efficiency, temperature, dissolved oxygen saturation and pH.

Label-Free Detection Systems for Biomolecular Interactions Analysis

Sartorius Octet® systems allow scientists to analyze molecular interaction in real time without the need for markers.

Ultrapure Water in the Lab

Type I reagent-grade water is essential in any laboratory and is used in nearly every lab procedure. Whether used to clean laboratory glassware, to prepare buffers and cell culture media or to perform critical laboratory applications, such as DNA sequencing, ultrapure water must have the appropriate degree of purity in order to ensure reliable research results.

Cell Harvesting

Sartoclear® depth filters were developed for demanding clarification applications in the biotechnological and pharmaceutical industries. The modular devices provide linear scalability from small to large scale processes.

Single-Use Filters

The preassembled Maxicaps® MR single-use filter configuration for the filtration of large volumes requires 90% fewer hoses and connections than comparable stainless steel systems.

Explore All Products

Video

Sartorius Video Loop

Download ZIP 220.1 MB

Sartorius Campus Video

Download ZIP 224.28 MB

Publications

Presentations Sartorius Group

Company Presentation Sartorius

PDF 2.4 MB

Download

Investors Presentation

PDF 4.5 MB

Download

Diversity Fact Sheet

PDF 2.0 MB

Download

Other Publications

Annual Report 2025

PDF 11.6 MB

Download

Universal Registration Document 2025

PDF 9.9 MB

Download

Sartorius Press Kit (Logos, Annual Report, CEO Image, Product Images)

ZIP 28.3 MB

Download

Insight | Sartorius in Profile

PDF 10.4 MB

Download

Sartorius Campus | Directions

PDF 3.7 MB

Download

Sartorius Campus | Sitemap

PDF 1.5 MB

Download

Book Projects

PROCESS PEOPLE PRODUCT

Three renowned photographers explore the world of Sartorius in the three-part coffee-table book Process – People – Product.

Learn More

Sartorius during the Third Reich

Professor Manfred Grieger researched and documented the activities of the company and its entrepreneurs during the Nazi era.

Learn More

Too Big for the Old Works

Impressions, stories and pictures remind us of the old main plant, where Sartorius' heart beat for almost 120 years.

Learn More

Sartorius 1870 - 2020

A team of authors examines the highs, lows, and technological advancements at Sartorius from a variety of viewpoints.

Learn More

PROCESS PEOPLE PRODUCT

Three renowned photographers explore the world of Sartorius in the three-part coffee-table book Process – People – Product.

Learn More

Sartorius during the Third Reich

Professor Manfred Grieger researched and documented the activities of the company and its entrepreneurs during the Nazi era.

Learn More

Too Big for the Old Works

Impressions, stories and pictures remind us of the old main plant, where Sartorius' heart beat for almost 120 years.

Learn More

Sartorius 1870 - 2020

A team of authors examines the highs, lows, and technological advancements at Sartorius from a variety of viewpoints.

Learn More

PROCESS PEOPLE PRODUCT

Three renowned photographers explore the world of Sartorius in the three-part coffee-table book Process – People – Product.

Learn More

Sartorius during the Third Reich

Professor Manfred Grieger researched and documented the activities of the company and its entrepreneurs during the Nazi era.

Learn More

Follow Us on Social Media

[icon-linkedin
\

LinkedIn](https://www.linkedin.com/company/15749)

[icon-instagram
\

Instagram](https://www.instagram.com/sartorius_group)

[icon-youtube
\

YouTube](https://www.youtube.com/user/SartoriusTV)

[icon-facebook
\

Facebook](https://www.facebook.com/sartoriusglobal/)

[icon-profile-search
\

Glassdoor](https://www.glassdoor.com/Overview/Working-at-Sartorius-EI_IE264283.11,20.htm)

[icon-kununu
\

kununu](https://www.kununu.com/de/sartorius)

Sartorius Logo

Downloads

Logo Usage Guidelines

How to Use the Logo | Clear Space, Sizes, and Colors

Placement

  • Preferred positions: top-left or bottom-right.
  • Choose the position that maximizes visibility and supports the layout. Keep the logo horizontal whenever possible.

Color options

Approved combinations:

  • Black on Yellow (preferred)
  • Black on White
  • White on Black
  • Do not use other colors, tints, or gradients. Ensure strong contrast for legibility.

Size and clear space

  • Standard size: approximately one-third of the page including clear space.
  • Always maintain ample clear space around the logo; keep text, images, or UI elements outside this area.

Don’ts

  • Do not place the logo inside a small yellow box or any tight shape.
  • Do not distort, rotate, recolor, or add effects (outlines, shadows, gradients).
  • Do not place the logo on busy backgrounds that reduce readability.

icon-application-center

Not Finding the Right Document?

If you can’t find a specific file, please contact Corporate Communications: [email protected]

Explore Sartorius

icon-building

Company

Learn More

icon-demographics

Careers

Learn More

icon-development-growth

Investor Relations

Learn More

Company

General Information

Language & Regions

EN | Worldwide

Newsletter & Social Media

Sign Up for Newsletter

© 2026 Sartorius AG

Language Preference

Please select your country so we can show you products that are available for you.

Canada Germany United Kingdom United States Argentina Australia Austria Belgium Brazil Bulgaria China Croatia Cyprus Czech Republic Denmark Estonia Finland France Greece Iceland India Indonesia Ireland Italy Japan Latvia Lithuania Malta Mexico Netherlands New Zealand Norway Philippines Portugal Romania Singapore Slovakia Slovenia Spain Sweden Switzerland Worldwide

The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.

EnglishDeutschFrançaisEspañolPortuguês中文 한국어 日本語Italiano

Save

Prompts

Sartorius Stedim Biotech S.A. (ticker DIM), listed in France.

ETFs Holding Sartorius Stedim Biotech S.A.

ETF Weight in ETF Shares Market value As of
FMED 2.56% 5,800 $ 1.32M Aug 31, 2026
MTRA 2.15% 15,555 $ 3.001M Jul 31, 2026
QLTI 1.30% 16,903 $ 3.848M Aug 31, 2026
GDOC 0.54% 467 $ 106.324K Aug 31, 2026
FWD 0.50% 70,359 $ 16.019M Aug 31, 2026
TOUS 0.21% 17,296 $ 3.344M Jul 31, 2026
RINT 0.12% 805 $ 167.034K Jun 30, 2026
DFAI 0.02% 15,954 $ 3.934M Nov 12, 2026
AVSD 0.02% 279 $ 68.592K Nov 16, 2026
NTSI 0.02% 471 $ 97.791K Jun 30, 2026
DFSI 0.02% 859 $ 211.796K Nov 12, 2026
DFIC 0.01% 6,682 $ 1.648M Nov 12, 2026
AVDE 0.01% 4,744 $ 1.166M Nov 16, 2026
DFAX 0.01% 3,836 $ 945.808K Nov 12, 2026